Advertisement
Canada markets open in 6 minutes

  • S&P/TSX

    21,740.20
    -159.79 (-0.73%)
     

  • S&P 500

    5,061.82
    -61.59 (-1.20%)
     

  • DOW

    37,735.11
    -248.13 (-0.65%)
     

  • CAD/USD

    0.7232
    -0.0022 (-0.30%)
     

  • CRUDE OIL

    85.07
    -0.34 (-0.40%)
     

  • Bitcoin CAD

    87,215.92
    -4,299.63 (-4.70%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • GOLD FUTURES

    2,388.30
    +5.30 (+0.22%)
     

  • RUSSELL 2000

    1,975.71
    -27.47 (-1.37%)
     

  • 10-Yr Bond

    4.6550
    +0.0270 (+0.58%)
     

  • NASDAQ futures

    17,884.00
    +7.75 (+0.04%)
     

  • VOLATILITY

    18.73
    -0.50 (-2.60%)
     

  • FTSE

    7,848.93
    -116.60 (-1.46%)
     

  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     

  • CAD/EUR

    0.6801
    -0.0023 (-0.34%)
     
BREAKING:

INFLATION IN CANADA UP SLIGHTLY TO 2.9% IN MARCH

On a seasonally adjusted monthly basis, the CPI increased 0.3% last month, says StatCan

Celldex Therapeutics to Present at SVB Securities Global Biopharma Conference

Celldex Therapeutics, Inc.
·1 min read
Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc.

HAMPTON, N.J., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in fireside chat at the SVB Securities Global Biopharma Conference today at 9:20 am ET. A webcast of the presentation will be available on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay will be available for 90 days following the event.

About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Visit www.celldex.com.

Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com

Patrick Till
Meru Advisors
(484) 788-8560
ptill@meruadvisors.com